Arcoma AB Total Liabilities

Latest as of March 2026: Skr26.30 Million SEK ≈ $2.83 Million USD

Arcoma AB total liabilities. Based on the latest financial reports, Arcoma AB (ARCOMA) has total liabilities worth Skr26.30 Million SEK (≈ $2.83 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ARCOMA financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Arcoma AB (2012–2025)

Total liabilities of Arcoma AB from 2012 to 2025. This chart illustrates how Arcoma AB's total liabilities have evolved over time, based on quarterly financial data.

Arcoma AB Competitors by Total Liabilities

The table below lists competitors of Arcoma AB ranked by their total liabilities.

Company	Country	Total Liabilities
Mr. Onion TWO:2740	Taiwan	NT$43.17 Million
MESB Bhd KLSE:7234	Malaysia	RM66.07 Million
Biofrontera Inc NASDAQ:BFRI	USA	$18.11 Million
Venteny Fortuna International JK:VTNY	Indonesia	Rp958.76 Billion
Elementis PLC LSE:ELM	UK	GBX470.87 Million
OXE Marine AB ST:OXE	Sweden	Skr163.98 Million
Khind Holdings Bhd KLSE:7062	Malaysia	RM126.37 Million
California Nanotechnologies Corp V:CNO	Canada	CA$1.61 Million

Liability Composition Analysis (2012–2025)

This chart breaks down Arcoma AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Arcoma AB total assets.

Liquidity & Leverage Metrics

Arcoma AB Total Liabilities Ratios Explained

Arcoma AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	3.12	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.35	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Arcoma AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Arcoma AB (2012–2025)

The table below shows the annual total liabilities of Arcoma AB from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr21.92 Million ≈ $2.36 Million	+3.76%
2024-12-31	Skr21.13 Million ≈ $2.27 Million	-36.56%
2023-12-31	Skr33.30 Million ≈ $3.58 Million	-38.84%
2022-12-31	Skr54.46 Million ≈ $5.86 Million	+54.57%
2021-12-31	Skr35.23 Million ≈ $3.79 Million	-22.57%
2020-12-31	Skr45.50 Million ≈ $4.90 Million	+19.28%
2019-12-31	Skr38.14 Million ≈ $4.10 Million	+2.43%
2018-12-31	Skr37.24 Million ≈ $4.01 Million	+36.52%
2017-12-31	Skr27.28 Million ≈ $2.94 Million	-19.55%
2016-12-31	Skr33.90 Million ≈ $3.65 Million	-1.26%
2015-12-31	Skr34.34 Million ≈ $3.69 Million	-8.40%
2014-12-31	Skr37.48 Million ≈ $4.03 Million	-35.77%
2013-12-31	Skr58.35 Million ≈ $6.28 Million	+31.57%
2012-12-31	Skr44.35 Million ≈ $4.77 Million	--

About Arcoma AB

ST:ARCOMA Sweden Medical Devices

Market Cap

$13.21 Million

Skr122.77 Million SEK

Market Cap Rank

#26198 Global

#541 in Sweden

Share Price

Skr8.58

Change (1 day)

-2.28%

52-Week Range

Skr6.92 - Skr9.80

All Time High

Skr25.60